MRS. JONNA IRISH PASCUAL MULLARKEY ARNP
Prescription History 1992111421
Nurse Practitioner - Family in Pittsburgh, PA
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for MRS. JONNA IRISH PASCUAL MULLARKEY ARNP, an active Family specialist practicing in Pittsburgh, PA. Our medical registry currently tracks 28 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 1,192 documented patient claims. Among these therapy options, the most frequently utilized medication is Lantus Solostar, which accounts for 126 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2023)Rx (2023) | Avg Cost per FillCost / Fill | Vs. Other PA PrescribersVs. PA Avg |
|---|---|---|---|
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 126 | $737.62 | ▲ More than typical |
About Lantus Solostar: Insulin glargine is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin glargine is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. It acts longer than regular insulin, providing a low, steady level of insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. Insulin glargine may be used with a shorter-acting insulin product. It may also be used alone or with other diabetes drugs. This monograph is about the following insulin glargine products: insulin glargine, insulin glargine-yfgn. A recombinant LONG ACTING INSULIN and HYPOGLYCEMIC AGENT that is used to manage BLOOD GLUCOSE in patients with DIABETES MELLITUS. In 2023, this provider wrote 126 Medicare prescriptions for Lantus Solostar, about 3.1 times the volume of the typical Pennsylvania prescriber of this medication (41). Medicare paid an average of $737.62 per fill, versus $552.83 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 267.4 30-Day Fills standardized to 30-day supplies 7,925 Days of Medication total across all patients in 2023 | |||
| TrulicityDulaglutide | 116 | $1,237.63 | ▲ More than typical |
About Trulicity: Dulaglutide is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. This medication is also used to lessen the risk of a major cardiovascular event (such as heart attack or stroke) in people who already have, or are at high risk for heart/blood vessel disease. Dulaglutide is similar to a natural hormone in your body (incretin). It works by causing insulin release in response to high blood sugar (such as after a meal) and by decreasing the amount of sugar your liver makes. Dulaglutide is not a substitute for insulin if you need insulin treatment. In 2023, this provider wrote 116 Medicare prescriptions for Trulicity, about 2.4 times the volume of the typical Pennsylvania prescriber of this medication (48). Medicare paid an average of $1,237.63 per fill, versus $1,235.23 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 145.8 30-Day Fills standardized to 30-day supplies 4,190 Days of Medication total across all patients in 2023 | |||
| OzempicSemaglutide | 102 | $1,270.81▼ below PA avg | ▲ More than typical |
About Ozempic: Semaglutide is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Semaglutide is also used in people with type 2 diabetes and heart disease to lower the risk of death from heart attack or stroke. Semaglutide is similar to a natural hormone in your body (incretin). It works by causing insulin release in response to high blood sugar (such as after a meal) and decreasing the amount of sugar your liver makes. If you use insulin, semaglutide is not a substitute for insulin treatment. In 2023, this provider wrote 102 Medicare prescriptions for Ozempic, about 2.3 times the volume of the typical Pennsylvania prescriber of this medication (44). Medicare paid an average of $1,270.81 per fill, versus $1,290.38 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 134.6 30-Day Fills standardized to 30-day supplies 3,879 Days of Medication total across all patients in 2023 | |||
| Levothyroxine Sodium | 84 | $17.46 | ▼ Less than typical |
About Levothyroxine Sodium: Levothyroxine is used to treat an underactive thyroid (hypothyroidism). Show more ▾ It replaces or provides more thyroid hormone, which is normally produced by the thyroid gland. Low thyroid hormone levels can occur naturally or when the thyroid gland is injured by radiation/medications or removed by surgery. Having enough thyroid hormone is important for maintaining normal mental and physical activity. In children, having enough thyroid hormone is important for normal mental and physical development. This medication is also used to treat other types of thyroid disorders (such as thyroid cancer). This medication should not be used to treat infertility unless it is caused by low thyroid hormone levels. The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism. In 2023, this provider wrote 84 Medicare prescriptions for Levothyroxine Sodium, about half the volume of the typical Pennsylvania prescriber of this medication (171). Medicare paid an average of $17.46 per fill, versus $16.47 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 218.9 30-Day Fills standardized to 30-day supplies 6,564 Days of Medication total across all patients in 2023 | |||
| Novolog FlexpenInsulin Aspart | 84 | $1,120.89 | ▲ More than typical |
About Novolog Flexpen: Insulin aspart is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin aspart is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. Insulin aspart starts working faster and lasts for a shorter time than regular insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This medication is usually used with a medium- or long-acting insulin product. Insulin that has been modified to contain an ASPARTIC ACID instead of a PROLINE at position 38 of the B-chain. In 2023, this provider wrote 84 Medicare prescriptions for Novolog Flexpen, about 2.3 times the volume of the typical Pennsylvania prescriber of this medication (37). Medicare paid an average of $1,120.89 per fill, versus $898.23 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 139 30-Day Fills standardized to 30-day supplies 4,084 Days of Medication total across all patients in 2023 | |||
| Metformin Hcl ErMetformin Hcl | 80 | $26.39 | ▲ More than typical |
About Metformin Hcl Er: Metformin is used with a proper diet and exercise program and possibly with other medications to control high blood sugar. Show more ▾ It is used in patients with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Metformin works by helping to restore your body's proper response to the insulin you naturally produce. It also decreases the amount of sugar that your liver makes and that your stomach/intestines absorb. A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289) In 2023, this provider wrote 80 Medicare prescriptions for Metformin Hcl Er, about 1.5 times the volume of the typical Pennsylvania prescriber of this medication (52). Medicare paid an average of $26.39 per fill, versus $13.63 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 216.1 30-Day Fills standardized to 30-day supplies 6,466 Days of Medication total across all patients in 2023 | |||
| Humalog Kwikpen U-100Insulin Lispro | 76 | $1,011.41 | ▲ More than typical |
About Humalog Kwikpen U-100: Insulin lispro is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin lispro is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. Insulin lispro starts working faster and lasts for a shorter time than regular insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This medication is usually used with a medium- or long-acting insulin product. Insulin lispro may also be used with other oral diabetes medications (such as sulfonylureas like glyburide or glipizide). Insulin that has been modified so that the B-chain contains a LYSINE at position 28 instead of a PROLINE and a PROLINE at position 29 instead of a LYSINE. It is used to manage BLOOD GLUCOSE levels in patients with TYPE 2 DIABETES. In 2023, this provider wrote 76 Medicare prescriptions for Humalog Kwikpen U-100, about 2.5 times the volume of the typical Pennsylvania prescriber of this medication (31). Medicare paid an average of $1,011.41 per fill, versus $843.87 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 140 30-Day Fills standardized to 30-day supplies 4,120 Days of Medication total across all patients in 2023 | |||
| MounjaroTirzepatide | 75 | $1,137.50▼ below PA avg | ▲ More than typical |
About Mounjaro: Tirzepatide is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. It lowers blood sugar by causing the release of your body's natural insulin and decreasing the amount of sugar your liver makes. A glucose-dependent insulinotropic polypeptide (GIP) receptor and Glucose-like peptide-1 (GLP-1) receptor agonist to enhance glycemic control in adults with TYPE 2 DIABETES MELLITUS. In 2023, this provider wrote 75 Medicare prescriptions for Mounjaro, about 4.4 times the volume of the typical Pennsylvania prescriber of this medication (17). Medicare paid an average of $1,137.50 per fill, versus $1,200.61 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 84 30-Day Fills standardized to 30-day supplies 2,384 Days of Medication total across all patients in 2023 | |||
| JardianceEmpagliflozin | 62 | $1,299.67 | ▲ More than typical |
About Jardiance: Empagliflozin is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Empagliflozin is also used in patients with type 2 diabetes and heart disease to lower the risk of death from heart attack or stroke. Empagliflozin works by increasing the removal of sugar by your kidneys. Empagliflozin is also used to treat heart failure. It may help you live longer and lower your risk of going to the hospital for heart failure. Empagliflozin works by increasing the removal of sodium by your kidneys. In 2023, this provider wrote 62 Medicare prescriptions for Jardiance, about 1.3 times the volume of the typical Pennsylvania prescriber of this medication (48). Medicare paid an average of $1,299.67 per fill, versus $939.26 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 143.1 30-Day Fills standardized to 30-day supplies 4,290 Days of Medication total across all patients in 2023 | |||
| Metformin Hcl | 44 | $12.03 | ▼ Less than typical |
About Metformin Hcl: Metformin is used with a proper diet and exercise program and possibly with other medications to control high blood sugar. Show more ▾ It is used in patients with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Metformin works by helping to restore your body's proper response to the insulin you naturally produce. It also decreases the amount of sugar that your liver makes and that your stomach/intestines absorb. A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289) In 2023, this provider wrote 44 Medicare prescriptions for Metformin Hcl, about a third of the volume of the typical Pennsylvania prescriber of this medication (106). Medicare paid an average of $12.03 per fill, versus $9.38 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 114 30-Day Fills standardized to 30-day supplies 3,389 Days of Medication total across all patients in 2023 | |||
| Nano 2nd Gen Pen NeedlePen Needle, Diabetic | 34 | $139.36 | ≈ Typical |
In 2023, this provider wrote 34 Medicare prescriptions for Nano 2nd Gen Pen Needle, about 1.2 times the volume of the typical Pennsylvania prescriber of this medication (29). Medicare paid an average of $139.36 per fill, versus $93.10 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 80.9 30-Day Fills standardized to 30-day supplies 2,420 Days of Medication total across all patients in 2023 | |||
| Tresiba Flextouch U-100Insulin Degludec | 28 | $596.21▼ below PA avg | ≈ Typical |
About Tresiba Flextouch U-100: Insulin degludec is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin degludec is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. It acts longer than regular insulin, providing a low, steady level of insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. Insulin degludec may be used with a shorter-acting insulin product. It may also be used alone or with other diabetes drugs. In 2023, this provider wrote 28 Medicare prescriptions for Tresiba Flextouch U-100, about the same volume as the typical Pennsylvania prescriber of this medication (28). Medicare paid an average of $596.21 per fill, versus $700.28 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 70.5 30-Day Fills standardized to 30-day supplies 2,073 Days of Medication total across all patients in 2023 | |||
| Methimazole | 28 | $23.13 | ≈ Typical |
About Methimazole: Methimazole is used to treat overactive thyroid (hyperthyroidism). Show more ▾ It works by stopping the thyroid gland from making too much thyroid hormone. A thioureylene antithyroid agent that inhibits the formation of thyroid hormones by interfering with the incorporation of iodine into tyrosyl residues of thyroglobulin. This is done by interfering with the oxidation of iodide ion and iodotyrosyl groups through inhibition of the peroxidase enzyme. In 2023, this provider wrote 28 Medicare prescriptions for Methimazole, about 85% of the volume of the typical Pennsylvania prescriber of this medication (33). Medicare paid an average of $23.13 per fill, versus $12.03 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 50.6 30-Day Fills standardized to 30-day supplies 1,419 Days of Medication total across all patients in 2023 | |||
| Humulin R U-500 KwikpenInsulin Regular, Human | 25 | $2,528.11 | ≈ Typical |
About Humulin R U-500 Kwikpen: Inhaled insulin powder is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. This man-made insulin product is the same as human insulin. It replaces the insulin that your body would normally make. It is a short-acting insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This product is absorbed into the blood through your lungs. It starts working faster and lasts for a shorter time than regular insulin injected under the skin. It is usually used in combination with a medium- or long-acting insulin product. This medication may also be used alone or with other oral diabetes drugs (such as metformin). In 2023, this provider wrote 25 Medicare prescriptions for Humulin R U-500 Kwikpen, about the same volume as the typical Pennsylvania prescriber of this medication (26). Medicare paid an average of $2,528.11 per fill, versus $1,676.19 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 25 30-Day Fills standardized to 30-day supplies 696 Days of Medication total across all patients in 2023 | |||
| SynthroidLevothyroxine Sodium | 25 | $61.01▼ below PA avg | ▼ Less than typical |
About Synthroid: Levothyroxine is used to treat an underactive thyroid (hypothyroidism). Show more ▾ It replaces or provides more thyroid hormone, which is normally produced by the thyroid gland. Low thyroid hormone levels can occur naturally or when the thyroid gland is injured by radiation/medications or removed by surgery. Having enough thyroid hormone is important for maintaining normal mental and physical activity. In children, having enough thyroid hormone is important for normal mental and physical development. This medication is also used to treat other types of thyroid disorders (such as thyroid cancer). This medication should not be used to treat infertility unless it is caused by low thyroid hormone levels. The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism. In 2023, this provider wrote 25 Medicare prescriptions for Synthroid, about half the volume of the typical Pennsylvania prescriber of this medication (44). Medicare paid an average of $61.01 per fill, versus $70.80 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 58.5 30-Day Fills standardized to 30-day supplies 1,720 Days of Medication total across all patients in 2023 | |||
| Glimepiride | 22 | $15.21▼ below PA avg | ▼ Less than typical |
About Glimepiride: Glimepiride is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Show more ▾ It may also be used with other diabetes medications. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Glimepiride belongs to the class of drugs known as sulfonylureas. It lowers blood sugar by causing the release of your body's natural insulin. Alkaloids derived from TYRAMINE combined with 3,4-dihydroxybenzaldehyde via a norbelladine pathway, including GALANTAMINE, lycorine and crinine. They are found in the AMARYLLIDACEAE plant family. In 2023, this provider wrote 22 Medicare prescriptions for Glimepiride, about half the volume of the typical Pennsylvania prescriber of this medication (44). Medicare paid an average of $15.21 per fill, versus $15.24 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 56 30-Day Fills standardized to 30-day supplies 1,680 Days of Medication total across all patients in 2023 | |||
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 21 | $632.03 | ▼ Less than typical |
About Basaglar Kwikpen U-100: Insulin glargine is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin glargine is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. It acts longer than regular insulin, providing a low, steady level of insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. Insulin glargine may be used with a shorter-acting insulin product. It may also be used alone or with other diabetes drugs. This monograph is about the following insulin glargine products: insulin glargine, insulin glargine-yfgn. A recombinant LONG ACTING INSULIN and HYPOGLYCEMIC AGENT that is used to manage BLOOD GLUCOSE in patients with DIABETES MELLITUS. In 2023, this provider wrote 21 Medicare prescriptions for Basaglar Kwikpen U-100, about 70% of the volume of the typical Pennsylvania prescriber of this medication (30). Medicare paid an average of $632.03 per fill, versus $382.38 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 61.3 30-Day Fills standardized to 30-day supplies 1,840 Days of Medication total across all patients in 2023 | |||
| Repaglinide | 20 | $302.28 | ▼ Less than typical |
About Repaglinide: Repaglinide is used alone or with other medications to control high blood sugar along with a proper diet and exercise program. Show more ▾ It is used in people with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. It works by stimulating the body to produce more insulin. Insulin is a natural substance that allows the body to properly use sugar from the diet. In 2023, this provider wrote 20 Medicare prescriptions for Repaglinide, about 67% of the volume of the typical Pennsylvania prescriber of this medication (30). Medicare paid an average of $302.28 per fill, versus $64.29 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 32 30-Day Fills standardized to 30-day supplies 960 Days of Medication total across all patients in 2023 | |||
| RybelsusSemaglutide | 19 | $1,562.63 | ≈ Typical |
About Rybelsus: Semaglutide is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Semaglutide is also used in people with type 2 diabetes and heart disease to lower the risk of death from heart attack or stroke. Semaglutide is similar to a natural hormone in your body (incretin). It works by causing insulin release in response to high blood sugar (such as after a meal) and decreasing the amount of sugar your liver makes. If you use insulin, semaglutide is not a substitute for insulin treatment. In 2023, this provider wrote 19 Medicare prescriptions for Rybelsus, about 83% of the volume of the typical Pennsylvania prescriber of this medication (23). Medicare paid an average of $1,562.63 per fill, versus $1,225.67 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 31 30-Day Fills standardized to 30-day supplies 930 Days of Medication total across all patients in 2023 | |||
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 19 | $978.37 | ≈ Typical |
About Toujeo Solostar: Insulin glargine is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin glargine is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. It acts longer than regular insulin, providing a low, steady level of insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. Insulin glargine may be used with a shorter-acting insulin product. It may also be used alone or with other diabetes drugs. This monograph is about the following insulin glargine products: insulin glargine, insulin glargine-yfgn. A recombinant LONG ACTING INSULIN and HYPOGLYCEMIC AGENT that is used to manage BLOOD GLUCOSE in patients with DIABETES MELLITUS. In 2023, this provider wrote 19 Medicare prescriptions for Toujeo Solostar, about 79% of the volume of the typical Pennsylvania prescriber of this medication (24). Medicare paid an average of $978.37 per fill, versus $699.22 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 55.1 30-Day Fills standardized to 30-day supplies 1,653 Days of Medication total across all patients in 2023 | |||
| Droplet Pen NeedlePen Needle, Diabetic | 15 | $64.39▼ below PA avg | ≈ Typical |
In 2023, this provider wrote 15 Medicare prescriptions for Droplet Pen Needle, about 79% of the volume of the typical Pennsylvania prescriber of this medication (19). Medicare paid an average of $64.39 per fill, versus $68.76 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 34.8 30-Day Fills standardized to 30-day supplies 1,034 Days of Medication total across all patients in 2023 | |||
| Insulin Glargine SolostarInsulin Glargine,hum.Rec.Anlog | 15 | $102.80 | – No State Data |
About Insulin Glargine Solostar: Insulin glargine is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin glargine is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. It acts longer than regular insulin, providing a low, steady level of insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. Insulin glargine may be used with a shorter-acting insulin product. It may also be used alone or with other diabetes drugs. This monograph is about the following insulin glargine products: insulin glargine, insulin glargine-yfgn. A recombinant LONG ACTING INSULIN and HYPOGLYCEMIC AGENT that is used to manage BLOOD GLUCOSE in patients with DIABETES MELLITUS. In 2023, this provider wrote 15 Medicare prescriptions for Insulin Glargine Solostar. Medicare paid an average of $102.80 per fill. No state comparison is available for this medication. How often this provider prescribes it No state benchmark is available for this medication. What Medicare paid per fill $102.80 Cost per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 21 30-Day Fills standardized to 30-day supplies 595 Days of Medication total across all patients in 2023 | |||
| Pioglitazone Hcl | 13 | $16.33▼ below PA avg | ▼ Less than typical |
About Pioglitazone Hcl: Pioglitazone is a diabetes drug (thiazolidinedione-type, also called glitazones) used along with a proper diet and exercise program to control high blood sugar in patients with type 2 diabetes. Show more ▾ It works by helping to restore your body's proper response to insulin, thereby lowering your blood sugar. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Pioglitazone is used either alone or in combination with other diabetes medications (such as metformin or a sulfonylurea such as glyburide). Talk to your doctor about the risks and benefits of pioglitazone. In 2023, this provider wrote 13 Medicare prescriptions for Pioglitazone Hcl, about a third of the volume of the typical Pennsylvania prescriber of this medication (33). Medicare paid an average of $16.33 per fill, versus $21.21 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 21 30-Day Fills standardized to 30-day supplies 630 Days of Medication total across all patients in 2023 | |||
| Lisinopril | 12 | $8.82 | ▼ Less than typical |
About Lisinopril: Lisinopril is used to treat high blood pressure. Show more ▾ Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. It is also used to treat heart failure and to improve survival after a heart attack. Lisinopril belongs to a class of drugs known as ACE inhibitors. It works by relaxing blood vessels so blood can flow more easily. One of the ANGIOTENSIN-CONVERTING ENZYME INHIBITORS (ACE inhibitors), orally active, that has been used in the treatment of hypertension and congestive heart failure. In 2023, this provider wrote 12 Medicare prescriptions for Lisinopril, about 9% of the volume of the typical Pennsylvania prescriber of this medication (135). Medicare paid an average of $8.82 per fill, versus $8.19 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 28 30-Day Fills standardized to 30-day supplies 840 Days of Medication total across all patients in 2023 | |||
| Levemir FlexpenInsulin Detemir | 12 | $1,130.27 | – No State Data |
About Levemir Flexpen: Insulin detemir is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin detemir is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. It acts longer than regular insulin, providing a low, steady level of insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. Insulin detemir may be used with a shorter-acting insulin product. It may also be used alone or with other diabetes drugs (such as metformin, exenatide). A recombinant long-acting insulin and hypoglycemic agent in which a MYRISTIC ACID is conjugated to a LYSINE at position B29. It is used to manage BLOOD GLUCOSE levels in patients with DIABETES MELLITUS. In 2023, this provider wrote 12 Medicare prescriptions for Levemir Flexpen. Medicare paid an average of $1,130.27 per fill. No state comparison is available for this medication. How often this provider prescribes it No state benchmark is available for this medication. What Medicare paid per fill $1,130.27 Cost per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 34.5 30-Day Fills standardized to 30-day supplies 1,030 Days of Medication total across all patients in 2023 | |||
| Insulin Lispro Kwikpen U-100Insulin Lispro | 12 | $314.44 | ▼ Less than typical |
About Insulin Lispro Kwikpen U-100: Insulin lispro is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin lispro is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. Insulin lispro starts working faster and lasts for a shorter time than regular insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This medication is usually used with a medium- or long-acting insulin product. Insulin lispro may also be used with other oral diabetes medications (such as sulfonylureas like glyburide or glipizide). Insulin that has been modified so that the B-chain contains a LYSINE at position 28 instead of a PROLINE and a PROLINE at position 29 instead of a LYSINE. It is used to manage BLOOD GLUCOSE levels in patients with TYPE 2 DIABETES. In 2023, this provider wrote 12 Medicare prescriptions for Insulin Lispro Kwikpen U-100, about half the volume of the typical Pennsylvania prescriber of this medication (28). Medicare paid an average of $314.44 per fill, versus $161.43 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 18 30-Day Fills standardized to 30-day supplies 505 Days of Medication total across all patients in 2023 | |||
| HumalogInsulin Lispro | 12 | $1,445.08 | ▼ Less than typical |
About Humalog: Insulin lispro is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin lispro is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. Insulin lispro starts working faster and lasts for a shorter time than regular insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This medication is usually used with a medium- or long-acting insulin product. Insulin lispro may also be used with other oral diabetes medications (such as sulfonylureas like glyburide or glipizide). Insulin that has been modified so that the B-chain contains a LYSINE at position 28 instead of a PROLINE and a PROLINE at position 29 instead of a LYSINE. It is used to manage BLOOD GLUCOSE levels in patients with TYPE 2 DIABETES. In 2023, this provider wrote 12 Medicare prescriptions for Humalog, about half the volume of the typical Pennsylvania prescriber of this medication (28). Medicare paid an average of $1,445.08 per fill, versus $631.50 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 27.4 30-Day Fills standardized to 30-day supplies 806 Days of Medication total across all patients in 2023 | |||
| Ultra-Fine Mini Pen NeedlePen Needle, Diabetic | 11 | $90.83 | ▼ Less than typical |
In 2023, this provider wrote 11 Medicare prescriptions for Ultra-Fine Mini Pen Needle, about half the volume of the typical Pennsylvania prescriber of this medication (21). Medicare paid an average of $90.83 per fill, versus $81.63 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 24.2 30-Day Fills standardized to 30-day supplies 725 Days of Medication total across all patients in 2023 | |||
About this data. The prescription history for MRS. JONNA IRISH PASCUAL MULLARKEY ARNP is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2023, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Family prescribing approach at this Pittsburgh, PA practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average volume among PA prescribers of the same medication. Always confirm current medications and costs directly with the provider and your plan.
